Cardiac P2X 4 receptors: Targets in ischemia and heart failure?

Circulation Research

Volumn 111, Issue 4, 2012, Pages 397-401

  Yang, Ronghua ^a   Liang, Bruce T ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

blood pressure; Calcium; contractility; ion channels; receptors (purinergic)

Indexed keywords

ADENOSINE TRIPHOSPHATE; CALCIUM ION; ENDOTHELIAL NITRIC OXIDE SYNTHASE; MRS 2339; PURINERGIC P2 RECEPTOR; PURINERGIC P2X4 RECEPTOR; PURINERGIC RECEPTOR BLOCKING AGENT; UNCLASSIFIED DRUG;

HEART; HEART FAILURE; HUMAN; ISCHEMIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; VASODILATATION;

ADENOSINE TRIPHOSPHATE; ANIMALS; CARDIOVASCULAR AGENTS; HEART FAILURE; HUMANS; MYOCARDIAL ISCHEMIA; MYOCARDIUM; PURINERGIC P2X RECEPTOR AGONISTS; RECEPTORS, PURINERGIC P2X4; SIGNAL TRANSDUCTION;

EID: 84864878185     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.112.265959     Document Type: Review

References (35)

1. Burnstock G. Purinergic receptors. J Theor Biol. 1976;62:491-503.
2. Fredholm BB, Abbracchio MP, Burnstock G, Daly JW, Harden TK, Jacobson KA, Leff P, Williams M. Nomenclature and classification of purinoceptors. Pharmacol Rev. 1994;46:143-156.
3. Khakh BS, Burnstock G. The double life of ATP. Sci Am. 2009;301: 84-92.
4. Szentmiklósi AJ. Novel trends in the treatment of cardiovascular disorders: site-and event-selective adenosinergic drugs. Curr Med Chem. 2011;18:1164-1187.
5. Mei Q, Liang BT. P2 purinergic receptor activation enhances cardiac contractility in isolated rat and mouse hearts. Am J Physiol Heart Circ Physiol. 2001;281:H334-H41.
6. Shen JB, Pappano AJ, Liang BT. Extracellular ATP-stimulated current in wild-type and P2X4 receptor transgenic mouse ventricular myocytes: implications for a cardiac physiologic role of P2X4 receptors. FASEB J. 2006;20:277-284.
7. Hu B, Mei QB, Yao XJ, Smith E, Barry WH, Liang BT. A novel contractile phenotype with cardiac transgenic expression of the human P2X4 receptor. FASEB J. 2001;15:2739-2741.
8. Shen JB, Shutt R, Pappano A, Liang BT. Characterization and mechanism of P2X receptor-mediated increase in cardiac myocyte contractility. Am J Physiol Heart Circ Physiol. 2007;293:H3056-H3062.
9. Zheng J, Boluyt M, Long X, O'Neill L, Lakatta E, Crow M. Extracellular ATP inhibits adrenergic agonist-induced hypertrophy of neonatal cardiac myocytes. Circ Res. 1996;78:525-535.
10. Pham T. UTP but not ATP causes hypertrophic growth in neonatal rat cardiomyocytes. J Mol Cell Cardiol. 2003;35:287-292.
11. Yamamoto K, Sokabe T, Matsumoto T, et al. Impaired flow-dependent control of vascular tone and remodeling in P2X4-deficient mice. Nat Med. 2006;12:133-137.
12. Stokes L, Scurrah K, Ellis JA, Cromer BA, Skarratt KK, Gu BJ, Harrap SB, Wiley JS. A loss-of-function polymorphism in the human P2X4 receptor is associated with increased pulse pressure. Hypertension. 2011; 58:1088-1092.
13. Hammond J, Balligand JL. Nitric oxide synthase and cyclic GMP signaling in cardiac myocytes: from contractility to remodeling. J Mol Cell Cardiol. 2012;52:330-340.
14. Sonin D, Zhou SY, Cronin C, Sonina T, Wu J, Jacobson KA, Pappano A, Liang BT. Role of P2X purinergic receptors in the rescue of ischemic heart failure. Am J Physiol Heart Circ Physiol. 2008;295:H1191-H1197.
15. Shen JB, Shutt R, Agosto M, Pappano A, Liang BT. Reversal of cardiac myocyte dysfunction as a unique mechanism of rescue by P2X4 receptors in cardiomyopathy. Am J Physiol Heart Circ Physiol. 2009;296: H1089-H1095.
16. Zhou SY, Mamdani M, Qanud K, Shen JB, Pappano AJ, Kumar TS, Jacobson KA, Hintze T, Recchia FA, Liang BT. Treatment of heart failure by a methanocarba derivative of adenosine monophosphate: implication for a role of cardiac purinergic P2X receptors. J Pharmacol Exp Ther. 2010;333:920-928.
17. Kessler S, Clauss W, Fronius M. Laminar shear stress modulates the activity of heterologously expressed P2X(4) receptors. Biochim Biophys Acta. 2011;1808:2488-2495.
18. Miklavc P, Mair N, Wittekindt OH, Haller T, Dietl P, Felder E, Timmler M, Frick M. Fusion-activated Ca2+ entry via vesicular P2X4 receptors promotes fusion pore opening and exocytotic content release in pneumocytes. Proc Natl Acad Sci USA. 2011;108:14503-14508.
19. Zhang YH, Youm JB, Earm YE. Stretch-activated non-selective cation channel: a causal link between mechanical stretch and atrial natriuretic peptide secretion. Prog Biophys Mol Biol. 2008;98:1-9.
20. Leychenko A. Stretch-induced hypertrophy activates NFkB-mediated VEGF secretion in adult cardiomyocytes. PLoS One. 2011;6:e29055.
21. Babelova A, Moreth K, Tsalastra-Greul W, Zeng-Brouwers J, Eickelberg O, Young MF, Bruckner P, Pfeilschifter J, Schaefer RM, Grone H-J, Schaefer L. Biglycan, a danger signal that activates the NLRP3 inflammasome via Toll-like and P2X4 receptors. J Biol Chem. 2009;284: 24035-24048.
22. de Rivero Vaccari JP, Bastien D, Yurcisin G, Pineau I, Dietrich WD, De Koninck Y, Keane RW, Lacroix S. P2X4 receptors influence inflammasome activation after spinal cord injury. J Neurosci. 2012;32: 3058-3066.
23. Gurung IS, Kalin A, Grace AA, Huang CL. Activation of purinergic receptors by ATP induces ventricular tachycardia by membrane depolarization and modifications of Ca2+ homeostasis. J Mol Cell Cardiol. 2009;47:622-633.
24. Coddou C, Yan Z, Obsil T, Huidobro-Toro JP, Stojilkovic SS. Activation and regulation of purinergic P2X receptor channels. Pharmacol Rev. 2011;63:641-683.
25. Balogh J, Wihlborg AK, Isackson H, Joshi BV, Jacobson KA, Arner A, Erlinge D. Phospholipase C and cAMP-dependent positive inotropic effects of ATP in mouse cardiomyocytes via P2Y11-like receptors. J Mol Cell Cardiol. 2005;39:223-230.
26. Wihlborg AK, Balogh J, Wang L, Borna C, Dou Y, Joshi BV, Lazarowski E, Jacobson KA, Arner A, Erlinge D. Positive inotropic effects by uridine triphosphate (UTP) and uridine diphosphate (UDP) via P2Y2 and P2Y6 receptors on cardiomyocytes and release of UTP in man during myocardial infarction. Circ Res. 2006;98:970-976.
27. Banfi C, Ferrario S, De Vincenti O, et al. P2 receptors in human heart: Upregulation of P2X6 in patients undergoing heart transplantation, interaction with TNFalpha and potential role in myocardial cell death. J Mol Cell Cardiol. 2005;39:929-939.
28. Nishidaa M, Ogushia M, Sudaa R, Toyotakaa M, Saikia S, Kitajimaa N, Nakayaa M, Kimb K, Idec T, Satod Y, Inouee K, Kurosea H. Heterologous down-regulation of angiotensin type 1 receptors by purinergic P2Y2 receptor stimulation through S-nitrosylation of NF-kB. Proc Natl Acad Sci USA. 2011;108:6662-6667.
29. Vessey DA, Li L, Kelley M. Pannexin-I/P2X 7 purinergic receptor channels mediate the release of cardioprotectants induced by ischemic pre-and postconditioning. J Cardiovasc Pharmacol Ther. 2010;15: 190-195.
30. Cosentino S, Banfi C, Burbiel JC, Luo H, Tremoli E, Abbracchio MP. Cardiomyocyte death induced by ischemic/hypoxic stress is differentially affected by distinct purinergic P2 receptors. J Cell Mol Med. 2012: 1074-1084.
31. Erlinge D, Burnstock G. P2 receptors in cardiovascular regulation and disease. Purinergic Signal. 2008;4:1-20.
32. Hattori M, Gouaux E. Molecular mechanism of ATP binding and ion channel activation in P2X receptors. Nature. 2012;485:207-212.
33. Kumar TS, Zhou SY, Joshi BV, Balasubramanian R, Yang T, Liang BT, Jacobson KA. Structure-activity relationship of (N)-methanocarba phosphonate analogues of 5′-AMP as cardioprotective agents acting through a cardiac P2X receptor. J Med Chem. 2010;53:2562-2576.
34. Ecke D, Hanck T, Tulapurkar ME, Schafer R, Kassack M, Stricker R, Reiser G. Hetero-oligomerization of the P2Y11 receptor with the P2Y1 receptor controls the internalization and ligand selectivity of the P2Y11 receptor. Biochem J. 2008;409:107-116.
35. Jacobson KA, Boeynaems JM. P2Y nucleotide receptors: promise of therapeutic applications. Drug Discov Today. 2010;15:570-578.